Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial

Yan Zhao, Jianzhong Zhang, Liming Wu et al.|Advances in Therapy|2025

Cited by 3